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Bacterial enzymes have long been considered solely accountable for the degradation of
the dentin matrix during the carious process. However, the emerging literature suggests
that host-derived enzymes, and in particular the matrix metalloproteinases (MMPs)
contained in dentin and saliva can play a major role in this process by their ability to
degrade the dentin matrix from within. These findings are important since they open
new therapeutic options for caries prevention and treatment. The possibility of using
MMP inhibitors to interfere with dentin caries progression is discussed. Furthermore, the
potential release of bioactive peptides by the enzymatic cleavage of dentin matrix proteins
by MMPs during the carious process is discussed. These peptides, once identified, may
constitute promising therapeutical tools for tooth and bone regeneration.
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INTRODUCTION
Enamel is the hardest structure of the organism, containing
about 96% of mineral but only traces of organic matrix (less
than 1%). The enamel carious process involves physicochemi-
cal reactions, where the mineral is dissolved by acids liberated
by cariogenic bacteria. In contrast, the dentin is less miner-
alized and contains an abundant organic material (19–20%),
mainly composed of type I collagen. Therefore, the dentin carious
process strongly differs from the enamel carious process. First,
the bacterial acids dissolve the dentin mineral, which progres-
sively uncovers the organic dentin extracellular matrix (ECM).
Second, proteases degrade the ECM components allowing the
progression of cariogenic bacteria toward pulp tissues. Such pro-
gression is facilitated by the tubular nature of the circumpulpal
dentin. It has long been assumed that dentin organic matrix is
degraded by proteases secreted by cariogenic bacteria. However,
bacterial collagenases have been shown to be highly pH sensi-
tive and not able to resist the acidic fall (pH 4.3) during the
demineralization phase of a pH cycling model (Kawasaki and
Featherstone, 1997), suggesting that this enzyme’s contribution to
dentin matrix degradation may be limited. Therefore, the poten-
tial role of host-derived proteases and in particular MMPs, in
dentin matrix degradation has been introduced. MMPs form a
mammalian family of ECM proteinases involved in normal and
pathological events in almost all tissues of the organism including
the tooth. MMPs present specific properties and characteris-
tics (Brinckerhoff and Matrisian, 2002), including their ability
to cleave matrix components, their dependence on a zinc ion
for activity, the requirement that the enzymes be activated by
the cleavage of a prodomain, the conservation of specific amino
acid sequences between family members, and inhibition of their
enzymatic activity by endogenous tissue inhibitors of metallo-
proteinases (TIMPs) (Visse and Nagase, 2003). Numerous stud-
ies have demonstrated endogenous proteolytic enzyme activity
within the dentin, including matrix metalloproteinases MMP-2,
MMP-9 and MMP-3 (Tjaderhane et al., 1998; Mazzoni et al.,
2007) which were shown to be required for normal dentin for-
mation. Once the neoformed dentin matrix mineralizes, some
of these enzymes remain trapped in the calcified matrix, either
under active or proenzyme forms (Palosaari et al., 2003). It can
be hypothesized that the cariogenic demineralization process not
only re-exposes these enzymes but also potentially induces their
activation. In addition, the saliva, which bathes the dentin car-
ious lesion, contains several proteases that can also participate
in the organic matrix degradation (Tjaderhane et al., 1998; Van
Strijp et al., 2003). The aim of the present article is to review the
role of the host metalloproteinases (MMPs) in the dentin carious
process. The ability of MMPs to liberate bioactive peptides and
degrade dentin matrix proteins as well as the potential use of pro-
tease inhibitors to block their activity in the treatment of caries
will be discussed.
DENTIN MATRIX PROTEINS
Dentin ECM consists of a 3D scaffold that is mainly formed of
type I collagen fibrils (90%). Types III and V collagens were also
identified in this scaffold but at lower levels (1–3%) (Goldberg
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and Smith, 2004; Opsahl Vital et al., 2012). Thin collagen fibrils
are secreted at the apical pole of the odontoblast body to form
the predentin (which is equivalent to the osteoid matrix in bone).
Collagen fibrils undergo fibrillogenesis along the predentin by
processes of self-assembly and cross-linking to form a template
which can be efficiently mineralized. Non-collagenous proteins
(NCPs), which have been the focus of intense studies in the
last decade because of their potential roles in the regulation of
bone and dentin mineralization, constitute the remaining 10%
of the ECM scaffold. It has been suggested that some NCPs are
associated with specific sites on collagen fibrils to regulate the
nucleation and growth of hydroxyapatite (HAP) crystals. For
example, the glycoaminoglycans (GAG) part of the proteoglycans
(PG) was shown to be important for the collagen fibril matu-
ration by delaying apatite crystals deposition to allow the fibrils
to reach a diameter sufficient to achieve proper mineralization
(Embery et al., 2001). The importance of NCPs in the mineral-
ization process has been well demonstrated by mutation studies
and by experimental suppression of NCP genes. These exper-
iments have highlighted the importance in the mineralization
process of SIBLINGs (Small Integrin Binding LIgand N-linked
Glycoproteins), a phosphoprotein family in which mutations
are associated with abnormal phenotypes in the mineralization
of bone and/or dentin (Qin et al., 2004; Opsahl Vital et al.,
2012). This family includes dentin sialophosphoprotein (DSPP),
dentin matrix protein 1 (DMP1), bone sialoprotein (BSP), matrix
extracellular phosphorylated glycoprotein (MEPE), and osteo-
pontin (OPN). It appears that the associations of these highly
phosphorylated and acidic NCPs with specific sites on collagen
molecules are essential in promoting the nucleation and growth
of apatite crystals. All SIBLINGs were identified in dentin and
bone ECM, but a high rate of DSPP expression was shown to
be specific to dentin. The SIBLING members carry an arginine–
glycine–aspartate (RGD) cell adhesion domain and a highly con-
served acidic serine and aspartate-rich motif (ASARM) (Rowe
et al., 2000; Fisher and Fedarko, 2003). Noteworthy, the func-
tion of ASARM domain in bone and teeth mineralization (apatite
crystals nucleator or inhibitor) is at present debated by the
scientific community, in particular its implication in patholog-
ical processes such as inherited rickets (Addison and Mckee,
2010; David and Quarles, 2010; Rowe, 2012). It is of inter-
est that, in addition to binding integrins SIBLINGs, may also
specifically bind and activate several MMPs in the ECM suggest-
ing that they could be involved in dentin matrix degradation
(Fedarko et al., 2004).
Dentin contains non-phosphorylated proteins, such as
osteonectin (SPARC protein or BM40) and proteins with
gamma-carboxylated glutamates (Gla) residues (osteocalcin and
matrix Gla protein-MGP-). While osteonectin may contribute to
the mineralization process, osteocalcin and MGP have been sug-
gested to regulate HAP crystal nucleation (Bronckers et al., 1998;
Onishi et al., 2005; Kaipatur et al., 2008). The small leucine-rich
proteoglycans (SLRPs), such as decorin, biglycan, fibromod-
ulin, lumican, and osteoadherin, have also been identified in
predentin and dentin (Goldberg et al., 1987, 2003a). Although
not specific to dentin and can be found in other mineralized or
non-mineralized tissues, they have been implicated in dentin
formation and mineralization (Embery et al., 2001). They are
thought to be involved in the transport of collagen fibrils through
the predentin and in collagen fibrillogenesis (Goldberg et al.,
2003a). Predentin is also rich in dermatan and chondroitin
sulphate-containing (PG). It is of interest that adjacent to the
mineralization front, predentin contains a large quantity of
keratan sulphate-containing PG associated with a dramatic
decrease in dermatan and chondroitin sulphate-containing PG.
This switch in the proteoglycan type was attributed to MMP-3,
which is closely related to a control of the dentin mineralization
process (Hall et al., 1999).
Dentin also contains α-2-Heremans Schmid-glycoprotein
(alpha-2-HSglycoprotein, AHSG), a serum protein currently
known as Fetuin-A. Fetuin-A is a serum protein produced in the
liver that concentrates in mineralized tissues, especially dentin
because of its high affinity for hydroxyapatite (Mazzoni et al.,
2012). The role for fetuins is to inhibit undesirable ectopic calcifi-
cation without affecting normal bone or dentin mineralization.
Interestingly, Fetuin-A can differentially control MMP-2 and -
9 activities, both as an inhibitor, activator or stabilizer of these
enzymes, depending on the enzyme and the time of binding (pro
or activated form) (Mazzoni et al., 2012).
MMPs IN NON-CARIOUS DENTIN
MMPs are believed to play an important role in thematrix remod-
eling that takes place during dentinogenesis. The main MMPs
identified in pulp, odontoblasts and in the predentin/dentin com-
partments are the collagenase MMP-8, the gelatinases MMP-2
and MMP-9, stromelysin-1 (MMP-3 or proteoglycanase), the
MMP-2 activator MMP-14 (MT1-MMP), MMP-13, and enam-
elysin (MMP-20) (Palosaari et al., 2002; Sulkala et al., 2002, 2004,
2007; Goldberg et al., 2003b; Bourd-Boittin et al., 2004; Boukpessi
et al., 2008; Mazzoni et al., 2009, 2011). TIMPs, their endogenous
inhibitors were also detected but at a lower level of expression
(Goldberg et al., 2003b; Palosaari et al., 2003). The expression
of MMP-2, the predominant MMP in sound dentin, was shown
to increase gradually from the onset of dentinogenesis to reach
maximal expression at day 6–7 post-natal (Bourd-Boittin et al.,
2005). MMP-2 is thought to play a key role in basement mem-
brane degradation which allows a direct epithelio-mesenchymal
contact, a prerequisite for odontoblasts and ameloblasts ter-
minal cytodifferentiation (Sahlberg et al., 1992; Heikinheimo
and Salo, 1995; Sahlberg et al., 1999). At the more advanced
stages of dentinogenesis, MMP-2 and MMP-9 were shown to
be located near the dentino-enamel junction (Goldberg et al.,
2002, 2003b), and a strong gelatinase activity was detected by in
situ zymography along the mantle dentin (Pessoa et al., 2013).
MMP-2 was shown to cooperate with MMP-20 in the process-
ing of dental ECM components, and particularly in that of DSPP
(Bourd-Boittin et al., 2004; Yamakoshi et al., 2006), or in the
self-processing mechanism of DSPP (Godovikova and Ritchie,
2007). Importantly, MMP-2 was isolated from mature human
mineralized dentin matrix (Martin-De Las Heras et al., 2000)
and zymographically identified in demineralized dentin (Van
Strijp et al., 2003; Mazzoni et al., 2007), suggesting a poten-
tial role in dentin ECM degradation during the carious process
(Tjaderhane et al., 1998; Chaussain-Miller et al., 2006). Recent
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studies described a differential profile of localization and activity
of the gelatinases in the different layers of human sound dentin
(Boushell et al., 2011; Niu et al., 2011). High levels of MMP-
2 were observed in odontoblasts where it was co-localized with
TIMP-2. It was also observed in the deep dentine and at the
dentinoenamel junction (Goldberg et al., 2003b). MMP-9, which
colocalized with TIMP-1, was also shown to decrease from the
deep to the superficial dentine layer (Niu et al., 2011). This gelati-
nase gradient may determine the rate of collagen degradation in
pathological conditions, depending on the depth of the affected
dentine.
Stromelysin-1 (MMP-3) has been identified in predentin,
where it was proposed to participate in the mineralization pro-
cess by degrading CS/DS (PG) (Hall et al., 1999) and in dentin
where it was shown localized within the intertubular dentine,
along the collagen fibrils (Mazzoni et al., 2011). Our own studies
have shown that this enzyme is present in demineralized dentin in
its active form, implying that it has the potential to degrade and
disorganize the dentin matrix. Indeed, we have shown that when
active, MMP-3 is able to cleave from the collagen scaffold several
matrix proteins such as decorin, biglycan as well as four members
of the SIBLING family: DSP, matrix extra-cellular phosphoglyco-
protein (MEPE), bone sialoprotein (BSP) and osteopontin (OPN)
(Boukpessi et al., 2008). The release by MMP-3 of (PG), such as
decorin, could result in a subsequent release of the sequestered
cytokines which in turn may activate other MMPs, thus poten-
tiating the degradation of the demineralized matrix (Imai et al.,
1997; Suppa et al., 2006).
POTENTIAL MECHANISM(S) OF MMP ACTIVATION IN
CARIOUS DENTIN
MMPs are secreted to the ECM as inactive proenzymes and then
require activation in order to be able to degrade matrix compo-
nents. During the caries process, the acidic environment created
by the release of bacterial acids can favor the activation of endoge-
nous MMPs. Low pH was suggested to cause a conformational
change within the propeptide domain of the enzyme that facili-
tates the cysteine switch, a critical step in the activation process
(Tjaderhane et al., 1998). However, although the activated MMPs
are stable in acidic pH, they can only be functional in neutral
pH. Neutralization of the acids can be achieved by the denti-
nal buffering mechanisms (Camps and Pashley, 2000; Haapasalo
et al., 2007) through the salivary buffer systems, thus allowing the
pH-activated MMPs to cleave matrix components (Tjaderhane
et al., 1998). In addition, the phosphorylated proteins released
from the collagen scaffold by bacterial acids could interact with
TIMP-inhibited MMPs within the carious lesion and re-activate
them, enhancing the degradation process (Fedarko et al., 2004).
Another enzyme family, the cysteine cathepsins, was identified
in dentin (Tersariol et al., 2010) and in saliva of patients with
periodontal conditions. They have also been reported in human
carious dentin (Van Strijp et al., 2003) and it was suggested that
these enzymes, when active, can in turn activate latent MMPs
(Van Strijp et al., 2003). Along this line, a recent study reported
a stronger immunostaining of cathepsins B in carious dentin,
observed in dentin tubules and in odontoblasts, when compared
with sound dentin (Nascimento et al., 2011). In addition, carious
dentin displayed increased cysteine cathepsin activity, which was
even greater in deep lesions with pulp exposure. Interestingly, it
was also shown in this study that MMP activity in the saliva was
higher in patients with active compared to chronic carious lesions,
while salivary cathepsins did not show respective correlation. The
reason may be that saliva is rich in cystatins (Dickinson, 2002),
potent cysteine peptidase inhibitors. On the other hand, cathepsin
activity increases with increasing depth of the lesion, indicating
the role of pulp tissue-derived enzymes (Nascimento et al., 2011).
Taken together, these studies suggest that cysteine cathepsins may
participate in the carious process at least partly by activating latent
MMPs.
DENTIN MATRIX DEGRADATION DURING THE CARIOUS
PROCESS
Host MMPs derived from dentin or saliva have been shown to
be able to degrade the dentin matrix which has been previ-
ously demineralized by bacterial acids (Tjaderhane et al., 1999;
Chaussain-Miller et al., 2006) (Figure. 1). Saliva contains sev-
eral MMPs including collagenases and gelatinases derived from
either the gingival crevicular fluid or the secretion of salivary
glands, MMP-9 being the most abundant as it is derived from
both sources (Van Strijp et al., 2003). Indeed, the incubation of
demineralized dentin slabs with acid-pretreated saliva resulted in
the degradation of the organic matrix (Van Strijp et al., 2003).
As saliva bathes the carious lesions, it is not surprising that the
active form of MMP-9 was systematically detected by zymog-
raphy performed on dentin extracts from several carious teeth
(Tjaderhane et al., 1998). Together these studies indicate that sali-
vary MMPs may have a strong contribution to dentin matrix
degradation during the caries process. Carious lesions were also
found to contain both latent and active forms of MMP-3, MMP-
2 and MMP-8 (Tjaderhane et al., 1998; Mazzoni et al., 2007;
Sulkala et al., 2007; Boukpessi et al., 2008). Along this line,
dentin protein extracts obtained from the different dentin lay-
ers of decayed teeth were shown to have their gelatinase activity
gradually increased from healthy dentin extracts to soft infected
dentin extracts (superficial soft carious lesion, inner soft car-
ious lesion, affected dentin, sound dentin) (Charadram et al.,
2012). These observations confirm that endogenous MMP-2 con-
tained within the sound dentin is activated during the carious
process (Figure. 2). It has also been suggested by immunohisto-
chemical observations that the endogenous MMP-2 level may be
increased through the induction of MMP-2 synthesis by the pres-
ence of caries (Toledano et al., 2010). This was supported by a
study showing that MMP-2 and TIMP-2 gene expressions were
significantly up-regulated in odontoblasts adjacent to the cari-
ous lesion (Charadram et al., 2012). Interestingly, several studies
have reported that in the cancer context, MMP expression by
tumor cells was up-regulated by an acidic extracellular pH (Kato
et al., 2005; Rofstad et al., 2006). This can suggest that acidic
pH during the carious process may both induce MMP expres-
sion by the odontoblasts and favor their activation, potentiating
MMP proteolytic capacity. In addition, the expression of MT1-
MMP, a potent activator of MMP-2 andMMP-20 (Palosaari et al.,
2002), was also dramatically increased in these cells, enhancing
dentin matrix degradation. In addition, MMP-2, MMP- 20 and
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FIGURE 1 | Schematic representation of MMP activity during the
dentin carious process. Cariogenic bacteria present in the caries cavity
release acids such as lactic acid that reduce the local pH. The resulting
acidic environment demineralizes the dentin matrix and induces the
activation of host MMPs derived from dentin or saliva (which bathes the
caries cavity). Once the local pH is neutralized by salivary buffer systems,
activated MMPs degrade the demineralized dentin matrix.
FIGURE 2 | SEM examination of the effects of MMP-2 on the dentin
matrix through low viscosity resin replicas. (A) Standardized human
dentin cubes were treated for 24 h with 0.5M lactic (pH 4.8) and resin
penetration in demineralized dentin was observed by resin replicas. The
low viscosity resin penetrates in the main dentin tubules. (B) The treatment
of demineralized dentin cubes by activated recombinant MMP-2 shows a
deeper resin penetration into the main dentin tubules, suggesting
increased dentin matrix degradation. Bar = 100mm.
cathepsin B were shown to be present in dentinal fluid, where
they may contribute to peritubular dentin degradation espe-
cially in young patients who have large and numerous dentin
tubules (Sulkala et al., 2002; Boushell et al., 2008; Tersariol et al.,
2010). Importantly, a study performed in a rat caries model
has shown that MMP inhibition by several synthetic inhibitors
reduced dentin caries progression under fissures (Sulkala et al.,
2001). This study not only confirms the role of host MMPs in
the caries process but also raises the possibility of using MMP
inhibitors for impairing dentin matrix degradation during the
caries.
MMP INHIBITORS FOR THE TREATMENT OF CARIOUS
DENTIN
Considering the potential role of MMPs in dentin ECM
degradation, it seems logical that, when associated with a thor-
ough control of the caries (Selwitz et al., 2007), MMP inhi-
bition would help to control dentin caries progression. This
notion was supported by studies in rat caries models where
dentin caries progression was delayed by intra-oral adminis-
tration of chemical MMP inhibitors (Tjaderhane et al., 1999;
Sulkala et al., 2001). Several effective MMP inhibitors have
been described. Tetracyclines and their derivatives, doxicycline
and minocycline are able to inhibit MMP activity indepen-
dent of their antimicrobial action. They are commonly used
as antibiotics in the treatment of periodontitis (Ryan et al.,
1996) and have been shown both in vitro and in vivo to inhibit
MMP-1, MMP-2, MMP-8 and MMP-12 (Golub et al., 1995;
Lauhio et al., 1995). Another effective and safe MMP inhibitor is
the non-antimicrobial chemically modified tetracyclines (CMTs),
which can inhibit both the release and the activity of MMPs
(Golub et al., 1998; Ramamurthy et al., 1998). Zoledronate
is a third generation bisphosphonate which has the ability to
inhibit MMP proteolytic activities (Teronen et al., 1997; Boissier
et al., 2000). Sulkala et al. (2001) have shown that the sys-
temic MMP inhibition with CMT-3 and zoledronate in vivo
suppressed the progression of dental caries under fissures, indi-
cating that systemic administration of MMPs inhibitors could
be effective in caries prevention (Sulkala et al., 2001). Indeed,
the authors observed a reduction in the progression of caries
in rats treated with these MMP inhibitors, though no syner-
gistic potentiating effect of these two compounds could been
demonstrated.
In humans, MMP inhibitors would preferably be administered
locally to treat dental caries by either incorporating them in topi-
cal preparations for daily use or by applying them directly on the
dentin surface, depending on the clinical situation. When treat-
ing coronal caries, especially in young patients with deep and
active caries lesions, a solution containing MMP inhibitors may
be applied directly to the lesion after the mechanical removal
of the caries and before restoration. A second strategy would
be to incorporate these inhibitors in mouth rinses or tooth-
pastes to prevent root caries progression. Several synthetic MMP
inhibitors are already used in the dental practice. The MMP
inhibitory action of most of them is based on their zinc-/calcium-
chelating groups, since MMPs require metal ions (calcium and
zinc) for their catalytic activity (Gendron et al., 1999). Among
them, Ethylenediaminetetraacetic acid (EDTA), which is an effec-
tive zinc and calcium chelator, was recently shown to inhibit
the degradation by acid-activated endogenous MMPs of dentin
beams treated for 1min with 17% EDTA (Thompson et al.,
2012). Chlorhexidine digluconate (CHX) has also potent MMP
inhibitor effects that also involve a calcium-chelating mechanism
(Gendron et al., 1999). These inhibitors have been shown to
improve the integrity of the hybrid layers obtained by a simplified
etch-and-rinse adhesive after dentin caries removal (Carrilho
et al., 2007). The local application of 2% CHX for 1min to the
etched dentin surface just before applying the dentin bonding
primer was able to inhibit the degradation of the hybrid layer by
MMPs for at least 14 months. This clinical study highlights that
CHX, a MMP inhibitor already used in dental practice, is able
to impair dentin matrix degradation. Interestingly, Scaffa et al.
demonstrated that CHX was also a potent inhibitor of the cys-
teine cathepsin enzymes (Scaffa et al., 2012), which were shown
to be present and active in sound and carious dentin (Tersariol
et al., 2010; Nascimento et al., 2011).
A different group of MMP inhibitors include those derived
from natural sources. Green tea polyphenols, especially
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FIGURE 3 | Early dentin repair in an injured rat pulp model induced by
the implantation of C-DMP1 peptide mimicking an MMP2 cleaved
peptide of DMP1.Beads soaked with c-DMP1 polypeptide were
implanted in the injured pulp of young rats. At day 7, osteopontin (OPN)
immunohistochemistry shows strong immunoreactivity of reparative
structures (arrowheads) observed in the injured pulp resembling
mineralization foci (Mckee et al., 1993). Bridge formation at longer time
points may partly result from growth and spreading of these mineralization
foci. At higher magnification (right panel), immunopositive cells (arrows)
are observed adjacent to the reparative structures.p: pulp; rd: reactionary
dentin; d: dentin.
epigallocatechin gallate (EGCG), were found to have potent
and distinct inhibitory activity against MT1-MMP, resulting in
the decrease of MMP-2 activation. Furthermore, EGCG inhibits
directly MMP-2 and MMP-9 (Demeule et al., 2000; Garbisa et al.,
2001; Dell’aica et al., 2002), and was recently shown to inhibit
dentinal erosion, along with other known MMP inhibitors (Kato
et al., 2010). Grape seed extract (GSE) has been shown to suppress
lipopolysaccharide-induced MMP secretion by macrophages and
to inhibit MMP-1 and MMP-9 activity in periodontitis (La et al.,
2009a). Recent in vitro studies demonstrated that GSE inhibited
the demineralization and/or promoted the remineralization of
artificial root carious lesions under dynamic pH- cycling condi-
tions (Xie et al., 2008; Pavan et al., 2011). The MMP-inhibitory
effects of these or other natural substances such as cranberry
proanthocyanidins (La et al., 2009b) suggest that they could be
effective in slowing down dentin caries progression. The fact
that these molecules are devoid of undesirable side effects, when
compared with those of synthetic drugs, makes them particu-
larly attractive for the treatment of dentin caries, since they can
be safely applied directly on the affected tooth or integrated in
daily-used topical products.
GENERATION OF BIOACTIVE PEPTIDES FROM DENTIN
MATRIX DEGRADATION
By cleaving large insoluble ECM components, MMPs are known
to liberate bioactive fragments and cytokines (Mott and Werb,
2004). The release of active peptides by the enzymatic cleavage
of dentin matrix proteins by MMPs during the carious process
was also suggested (Chaussain-Miller et al., 2006). These pep-
tides, which often retain the activity of the parent protein (Dean
and Overall, 2007), or display a function different from those of
the protein they are derived from, can affect several biological
properties in terms of proliferation, angiogenesis, differentiation
that may favor the pulp healing process (Dean et al., 2007; Smith
et al., 2012a). In particular, the degradation of matrix (PG), which
often bind and sequester growth factors, by proteases such as the
MMP-3 would cause the release and activation of these factors
within the carious lesion and can as a result impact pulp healing
(Smith et al., 2012b). The gelatinase MMP-2 has been proposed
to be able to release active TGF-β2 in the carious lesion, which
can then stimulate diverse repair processes (Charadram et al.,
2012).
Using an injured rat pulp model to test the biological prop-
erties of such cleavage products derived from the (ECM), we
demonstrated that a polypeptide containing the C-terminal part
of DMP1, and mimicking DMP1 cleavage product by MMP-
2, was able to enhance pulp healing capacity when implanted
in a rat pulp-injury model (Chaussain et al., 2009). A dense
and continuous reparative dentin bridge was rapidly observed
after implantation and the cells boarding the bridge presented
a characteristic polarized odontoblastic phenotype, organized as
a palisade and expressing the odontoblastic markers DSP and
DMP1 (Figure 3). The use of such ECM-derived bioactive pep-
tides associated with restorative materials constitutes a promising
therapeutical option for tooth repair (Goldberg et al., 2008). In
addition, these peptides may also be used for bone regeneration,
potentially associated with engineered scaffolds and mesenchy-
mal stem cells (Mao et al., 2006), as dentin and bone are similar
in several aspects, especially pertaining to the composition of the
ECM (Opsahl Vital et al., 2012).
In conclusion, accumulating data have demonstrated that
endogenous enzymes contained in dentin and saliva are involved
in the dentin caries process. These findings are important, since
they open new options for caries prevention and treatment.
Slowing down or preventing the irreversible destruction of the
organic matrix would allow for natural healing of the lesion by
remineralization. MMP inhibitors may prove to be useful in the
prevention of dentin caries progression. However, the outcomes
of this approach will depend on the management of the caries
risk, involving the control of caries risk factors such as cario-
genic biofilm, diet, inadequate salivary flow rate and insufficient
fluoride exposure (Selwitz et al., 2007).
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